What’s a gynaecology tumor?
What is the gynaecology tumor: an important issue for women’s health?
Gynaecological tumours are tumours occurring in the female reproductive system in areas such as uterus, ovaries, cervix, vagina, vagina, etc. Gynaecology tumours are an important issue in women ‘ s health, and their incidence increases each year and has become an important factor in women ‘ s fertility and quality of life. Although many gynaecological neoplasms are benign, some of them, such as cervical cancer and ovarian cancer, can lead to serious health consequences and even endanger life. Therefore, basic knowledge of gynaecology tumours, early symptoms and screening methods are essential for women.
I. Common types of gynaecological tumours
Cervical cancer
Cervical cancer is one of the most common malignant neoplasms in the female reproductive system, caused mainly by the persistent infection of the HPV virus, a high-risk human papilloma virus. HPV infections lead to cervix cell mutations, which in turn develop into cancer. The early stages of cervical cancer usually do not show visible symptoms, but with the development of the condition, abnormal vaginal haemorrhage, an increase in vaginal genres, and back pains may occur. Cervical cancer screening methods include cervical cytology (Pap smear) and HPV testing.
2. ovarian cancer
The cancer of ovarians is a malignant tumour in the female reproductive system, usually with no visible symptoms at an early stage, and is therefore known as the “silent killer”. Risk factors for ovarian cancer include age, family history, prolonged pregnancy, etc. Symptoms of ovarian cancer include abdominal expansion, loss of appetite, loss of weight, frequent urination, etc. Because of their early detection, many ovarian cancer patients were at an advanced stage of diagnosis.
3. Endeminal uterine cancer
Cervical membrane cancer is a malignant tumour occurring in the uterine membrane, which is common among post-menopausal women. It is often associated with long-term estrogen irritation, such as obesity, diabetes or uncontrolled hormone substitution treatment. The common symptoms of intrauterine cancer are abnormal vaginal haemorrhage, especially after menopause. Cervical membrane cancer can be detected at an early stage by means of ultrasound and uterine membrane activity.
4. Cervical musculoma
The cervioma is one of the most common benign tumours in women, usually in their reproductive years. Although uterine membranes are mostly benign, in some cases their increase may affect women ‘ s fertility or lead to serious symptoms. Symptoms of uterus aneurysm include menstrual abnormalities, abdominal swelling, pelvic pain, urine frequency, etc. Diagnosis of uterine musculoma relies mainly on ultrasound examination, and may require surgical treatment if the musculoma is large or causes symptoms.
5. Vulva and vaginal cancer
Vulva and vaginal cancer are relatively rare malignant gynaecological tumours, often associated with chronic inflammation, HPV infections, etc. Symptoms of vaginal cancer include larvae, swelling, ulcers, etc., while vaginal cancer is often manifested in increased vaginal haemorrhage or secretives. Due to the low incidence of these tumours, many women are not sufficiently aware of them, resulting in late symptoms.
II. Symptoms of gynaecological tumours
The symptoms of gynaecological tumours vary according to type. Common symptoms include:
Abnormal vaginal haemorrhage: haemorrhage after sexual intercourse, irregular menstruation, post-menopausal haemorrhage, may be early symptoms of cervical cancer, intrauterine cancer, etc.
The increase in vaginal genres: the increase in genres and their associated aroma may indicate cervical or uterine membrane cancer.
pelvic pain or abdominal discomfort: Diseases such as ovarian cancer and uterine myooma are often manifested in persistent abdominal pain or lower abdominal pain.
Menstruation: Menstruation, such as excessive menstruation, menstruation, etc., is common in uterine membrane, uterine membrane, etc.
Peeing, defecation abnormalities: When tumors oppress bladders or rectals, they can lead to symptoms such as urination frequency, urination difficulties or constipation.
It is important to note that many gynaecological tumours have early symptoms that are not visible or are similar to other common gynaecological diseases, and that regular gynaecological examinations and early screening are therefore important.
Screening for gynaecological tumours and early detection
Periodic screening for gynaecology tumours is key to early detection of tumours and to improving cure rates. Common gynaecology cancer screening methods include:
Cervical cancer screening: Cervical cancer screening is mainly based on cervical cytology (Pap smear) and HPV testing. Cervical cancer screening for women should be initiated after the age of 21, and every three years. A joint HPV test may be considered for women aged 30 and over, once every five years.
2. Cervical membrane screening: For women with symptoms such as post-menopausal vaginal haemorrhage, the doctor will recommend an endomerid screening to check for any carcinogenic changes. Ultrasound screening is also an important tool for early screening, especially among high-risk groups with symptoms.
3. Screening for ovarian cancer: screening for ovarian cancer is more difficult and there is currently no uniform screening standard. For high-risk groups (e.g. women with a history of ovarian cancer) periodic ultrasound examinations and oncological markers CA-125 can be considered.
4. Cervical membrane screening: screening for uterine membrane relies mainly on ultrasound. Women with symptoms, especially those with irregular menstruation or abdominal swelling, should be treated as early as possible for ultrasound or other visual tests.
Treatment of gynaecological tumours
The treatment of gynaecological tumours varies according to the type of tumor, the progress of the condition and the patient ‘ s state of health. Common treatment methods include:
1. Surgery: In the case of a benign gynaecology tumor (e.g. uterus tumour), an operation may be required if the tumor is large or causes symptoms. For malignant tumours (e.g. cervical, ovarian, etc.), surgery is an important means of treatment, especially at an early stage.
2. Demobilisation and chemotherapy: In the case of certain malignant gynaecological tumours, demobilisation and chemotherapy can be used as complementary treatments to help control the condition and extend the duration of life.
Hormonal treatment: hormonal treatment can help control conditions for certain gynaecological tumours (e.g. uterine, ovarian, etc.) dependent on hormone growth.
Targeting treatment and immunisation treatment: As medical science and technology develop, target-oriented treatment and immunisation treatment are becoming new options for some gynaecological tumour treatments, especially in late or recurring cases.
V. Prevention of gynaecology
Although not all gynaecology tumours are fully preventable, the risk of disease can be significantly reduced through healthy lifestyles and regular screening. Common preventive measures include:
Vaccination against HPV: HPV is an effective means of preventing high-risk HPV infections that cause cervical cancer, and women aged 9-45 are recommended for vaccination.
Maintaining healthy weight and diet: Avoiding obesity and maintaining a balanced diet helps to reduce the risks of uterine and ovarian cancers.
Regular medical check-ups and screenings: periodic gynaecological examinations are conducted to detect potential gynaecological diseases in a timely manner.
Avoiding unhealthy sexual habits: using condoms and reducing the risk of transmission of sexually transmitted diseases such as HPV.
Concluding remarks
Gynaecology tumours are an important subject of women ‘ s health, and early detection and timely treatment can significantly increase the cure rate. Women are required to conduct regular gynaecological examinations to monitor physical abnormalities and to maintain a healthy lifestyle in order to prevent and respond effectively to gynaecological tumours.
